EUVIMEDEUVIMED entdecken
Crossref

Intravenous Ampicillin/Sulbactam in Critically Ill Dogs has Variable Pharmacokinetics

Robert Goggs iD, Sarah Robbins, Julie Menard iD, Jamie Selman, Jeff Beverly iD, Sydney Kraus-Malett, Mark G Papich

Journal of Veterinary Pharmacology and Therapeutics · 2025

DOI: 10.1111/jvp.70004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2025. Verfasst von Robert Goggs und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Sulbactam, Ampicillin, Anti-Bacterial Agents, Dog Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Cornell University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achieving therapeutic plasma concentrations is essential for effective antimicrobial drug (AMD) treatment. Critical illness alters drug distribution and clearance, potentially impacting AMD effectiveness. We conducted a prospective observational study in 25 critically ill dogs to evaluate the pharmacokinetics (PK) of intravenous (IV) ampicillin/sulbactam and achievement of the efficacy target of ≥ 50% of the dosing interval with unbound plasma drug concentrations above the minimum inhibitory concentration ( f T > MIC). All dogs received IV ampicillin/sulbactam from a commercial formulation at a dosage of 20 mg/kg ampicillin/10 mg/kg sulbactam. Plasma concentrations were measured using liquid chromatography–mass spectrometry. PK modeling determined best‐fit compartmental models, and Monte Carlo simulations evaluated the probability of target attainment for bacterial MICs. A one‐compartment model best described ampicillin PK, while a two‐compartment model fit sulbactam. Monte Carlo simulations indicated a 90% probability that ampicillin at 20 mg/kg IV q8 h would achieve the Clinical and Laboratory Standards Institute (CLSI) veterinary breakpoint of 0.25 μg/mL for > 50% of the dosing interval. There was only a 10% probability of achieving the human breakpoint of 8 μg/mL. At 0.25 μg/mL, most Enterobacterales isolates would be resistant. The ampicillin/sulbactam dosage tested meets veterinary CLSI standards for ampicillin but might not effectively treat Enterobacterales infections in critically ill dogs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulbactamAmpicillinAnti-Bacterial AgentsDog DiseasesAnimalsDogsCritical IllnessMaleFemaleProspective StudiesMicrobial Sensitivity TestsMonte Carlo MethodAdministration, Intravenous

Stichwörter der Autor:innen

Monte Carlo simulationsantimicrobial drugsantimicrobial resistancepharmacodynamicspharmacokineticsprobability of target attainment

Substanzen

SulbactamAmpicillinAnti-Bacterial Agentssultamicillin

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Comparative Coagulation Laboratory, Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Molecular Biomedical Sciences, NC State University, Raleigh, North Carolina, USA.

ORCID-Profile: Robert Goggs, Julie Menard, Jeff Beverly

Förderung

  • Cornell University

Zitieren

APA

Goggs, R., Robbins, S., Menard, J., Selman, J., Beverly, J., Kraus-Malett, S., & Papich, M. G. (2025). Intravenous Ampicillin/Sulbactam in Critically Ill Dogs has Variable Pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70004

Vancouver

Goggs R, Robbins S, Menard J, Selman J, Beverly J, Kraus-Malett S, et al. Intravenous Ampicillin/Sulbactam in Critically Ill Dogs has Variable Pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics. 2025. doi:10.1111/jvp.70004

BibTeX
@article{Goggs2025,
  author = {Goggs, Robert and Robbins, Sarah and Menard, Julie and Selman, Jamie and Beverly, Jeff and Kraus-Malett, Sydney and Papich, Mark G},
  title = {Intravenous Ampicillin/Sulbactam in Critically Ill Dogs has Variable Pharmacokinetics},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.1111/jvp.70004}
}
Kostenlos starten →